East Windsor, New Jersey, October 2, 2007 — Abbott announced today that the U.S. Food and Drug Administration (FDA) has granted waived status under the Clinical Laboratory Improvement Amendements of ...
The test measures glial fibrillary acidic protein and ubiquitin carboxyl-terminal hydrolase L1, biomarkers present in blood plasma at elevated concentrations after a brain injury. The Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results